DG Peptide Protocols
Well StudiedCognitiveLongevity

NA Semax Amidate

N-Acetyl Semax Amidate

Enhanced Nootropic Peptide | Cognitive Enhancement & Neuroprotection

Half-life
2-10 hours
Chain length
Not reported
Reference frequency
1-2x daily for 10-30 days

Research overview

DoseGear research brief

Enhanced and stabilized version of Russian nootropic Semax with superior stability, extended half-life, and enhanced bioavailability through acetylation and amidation modifications.

Mechanism of action

Bypasses blood-brain barrier via olfactory nerves with direct brain access; enhances BDNF upregulation and hippocampal plasticity.

Compound background

Development & research timeline

Study windows describe what researchers measured, not when an individual should expect a result.

Origin & development

Acetylated and amidated Semax derivative.

What it is researched for

Proposed cognitive and neuroprotective research based on parent-like neurotrophic signaling; direct validation is limited.

Research observation window

Not reported for this derivative.

Reference data

Lyophilized vial injectable protocols

Not personalized dosing instructions

Only injectable vial references are shown. Nasal, topical, and unsupported non-vial schedules are excluded.

No sourced lyophilized-vial injectable protocol is listed for this profile.

Safety context

Reported side effects

  • Mild nasal irritation (intranasal)
  • Slight headache initially

Contraindications & cautions

  • Not recommended during pregnancy
  • Active nasal congestion or sinus infection
  • Individuals on neurotransmitter-affecting medications without consultation

Scientific references

  1. 01

    A Nootropic Adrenocorticotropin Analog 4-10 Semax: 15 Years Experience in Its Design and Study (Parent Compound)

    Scientific citationA Nootropic Adrenocorticotropin Analog 4-10 Semax: 15 Years Experience in Its Design and Study (Parent Compound). Zhurnal Vysshei Nervnoi Deiatelnosti imeni I.P. Pavlova (1997).
  2. 02

    Effects of Semax on the Default Mode Network of the Brain (Parent Compound)

    Scientific citationEffects of Semax on the Default Mode Network of the Brain (Parent Compound). Bulletin of Experimental Biology and Medicine (2018).
  3. 03

    The Efficacy of Semax in the Treatment of Patients at Different Stages of Ischemic Stroke (Parent Compound)

    Scientific citationThe Efficacy of Semax in the Treatment of Patients at Different Stages of Ischemic Stroke (Parent Compound). Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova (2018).
  4. 04

    The Peptide Semax Affects the Expression of Genes Related to the Immune and Vascular Systems in Rat Brain Focal Ischemia (Parent Compound)

    Scientific citationThe Peptide Semax Affects the Expression of Genes Related to the Immune and Vascular Systems in Rat Brain Focal Ischemia (Parent Compound). BMC Genomics (2014).

This DoseGear profile combines published scientific literature with lyophilized-vial protocol references. Citations are provided for independent review.

Related research profiles